The INCORRECT Statement is C
Statement C ("Antimicrobial therapy prevents streptococcal complications") is incorrect because antibiotic treatment does NOT prevent all streptococcal complications—specifically, it does not prevent poststreptococcal glomerulonephritis.
Analysis of Each Statement
Statement A: Microbiological confirmation is necessary - CORRECT
While this patient has classic features of Group A Streptococcal (GAS) pharyngitis (fever, tonsillar exudate, anterior cervical lymphadenopathy), microbiological confirmation remains necessary in adults 1. The IDSA guidelines explicitly state that while clinical algorithms without microbiological confirmation have been suggested for adults, this approach would result in treating "an unacceptably large number of adults with non-streptococcal pharyngitis" 1.
- GAS causes only 5-15% of acute pharyngitis cases in adults 1
- Clinical features alone overestimate the probability of GAS infection 1
- Testing prevents overprescription of antimicrobials 1
Statement B: Empirical antimicrobial therapy may be given - CORRECT
Despite the recommendation for testing, empirical therapy based on clinical findings is an acceptable practice in certain circumstances, particularly when:
- Clinical features strongly suggest GAS pharyngitis
- Testing is unavailable or delayed
- The patient meets criteria on validated clinical prediction rules 1
The guidelines acknowledge that clinical algorithms can predict GAS with reasonable accuracy (32-56% depending on features present) 1, making empirical treatment a viable option even if not ideal.
Statement C: Antimicrobial therapy prevents streptococcal complications - INCORRECT
This is the false statement. The guidelines explicitly state: "treatment of pharyngitis does not affect the development of poststreptococcal glomerulonephritis" 1.
While antimicrobial therapy does:
- Prevent acute rheumatic fever (ARF) when given within 9 days of symptom onset 1
- Reduce suppurative complications (peritonsillar abscess, cervical lymphadenitis)
- Decrease transmission to others 1
It does NOT prevent all complications, specifically failing to prevent poststreptococcal glomerulonephritis 1. This is a critical distinction that makes statement C factually incorrect.
Statement D: Glucocorticoids may be given for severe symptoms - CORRECT
While not explicitly detailed in the provided guidelines, glucocorticoid use for severe pharyngitis symptoms (particularly when there is significant tonsillar hypertrophy causing airway compromise or severe odynophagia) is an accepted clinical practice. This is particularly relevant given that the patient's presentation could also represent infectious mononucleosis 2, where corticosteroids are sometimes used for severe tonsillar enlargement with airway compromise.
Statement E: Odynophagia with inability to ingest fluids warrants admission - CORRECT
This represents a clear indication for hospitalization due to:
- Risk of dehydration
- Inability to take oral medications
- Potential airway compromise
- Need for intravenous hydration and possibly parenteral antibiotics
This is standard clinical practice for managing severe pharyngitis complications.
Clinical Pitfalls
Important caveat: In this 19-year-old with classic pharyngitis features, consider infectious mononucleosis in the differential diagnosis 2. The presence of posterior cervical adenopathy (positive LR 3.1), splenomegaly, or palatine petechiae would significantly increase the likelihood of mononucleosis rather than GAS pharyngitis 2. Testing for both conditions may be warranted, as treatment approaches differ significantly.